New FDA warnings on NSAIDs and COX-2s are causing a return to basics for pain management

New FDA warnings on NSAIDs and COX-2s are causing a return to basics for pain management.

All Rx NSAIDs will have a new boxed warning about GI and cardiovascular risk. Patients will get a new Medication Guide when they fill their prescriptions.

Celebrex (celecoxib) will have a Medication Guide, plus a boxed warning, plus clinical trial data on cardiovascular risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote